New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 30, 2014
08:16 EDTAUXLAuxilium revenue outlook cut removes overhang, says Leerink
Leerink believes Auxilium's revenue outlook reduction is not surprising since Testim prescriptions have been declining 26% annually and 16% compared to last quarter. The firm says the news removes an overhang on the stock and points out that Testim represents only $1 of its $36 price target for shares. Leerink keeps an Outperform rating on Auxilium.
News For AUXL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 21, 2014
08:13 EDTAUXLBioSpecifics announces FDA approval of sBLA for XIAFLEX
Subscribe for More Information
October 20, 2014
17:33 EDTAUXLAuxilium announces XIAFLEX approved for treatment of up to two DC joints
Subscribe for More Information
October 13, 2014
06:41 EDTAUXLEndo upgraded to Hold from Sell at Cantor
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use